Sommerville Scott M M, Patton James T, Luscombe Jon C, Mangham D Chas, Grimer Robert J
Consultant Orthopaedic Surgeon, The Wesley Hospital, Brisbane, Australia.
ANZ J Surg. 2005 Sep;75(9):803-6. doi: 10.1111/j.1445-2197.2005.03519.x.
Controversy exists with regard to the nomenclature, treatment and outcome of a group of well-differentiated lipomatous tumours sometimes labelled as atypical lipomas. The purpose of the present paper is to attempt to clarify these controversies by reporting our experience with this lesion.
The clinical features and follow up of 61 patients with the diagnosis of deep atypical lipoma and a minimum two-year follow up were examined.
All patients were treated by marginal excision alone. A local recurrence was seen in five patients (8%). Three recurred once and two recurred twice. No patient had a metastasis or died as a result of the tumour. No lesion dedifferentiated.
We believe the term atypical lipoma is appropriate for these tumours, as they appear not to have any metastatic potential, merely a propensity to recur locally. The chance of dedifferentiation is small and radiotherapy may play a role in its causation. We suggest that a simple marginal resection (shelling-out) is adequate treatment for these lesions. Radiotherapy should not be used.
对于一组有时被标记为非典型脂肪瘤的高分化脂肪性肿瘤,在命名、治疗及预后方面存在争议。本文旨在通过报告我们对该病变的经验来试图澄清这些争议。
对61例诊断为深部非典型脂肪瘤且至少随访两年的患者的临床特征及随访情况进行了检查。
所有患者均仅接受了边缘切除治疗。5例患者(8%)出现局部复发。3例复发一次,2例复发两次。无患者因肿瘤发生转移或死亡。无病变发生去分化。
我们认为非典型脂肪瘤这一术语适用于这些肿瘤,因为它们似乎没有任何转移潜能,只是有局部复发的倾向。去分化的可能性较小,放疗可能在其发生中起作用。我们建议对这些病变进行简单的边缘切除(剜除术)就足够了。不应使用放疗。